HSCT

Gecacitinib in the Treatment of Steroid-Refractory/Dependent Chronic Graf Versus Host Disease (cGVHD).

Gecacitinib Pre-, During- and Post-HSCT for Patients With Primary or Secondary Myelofibrosis

The Efficacy and Safety of Stereotactic Radiotherapy Bridging Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Malignance Patients With Extramedullary Infiltrating

The Efficacy and Safety of Luspatercept in Improving Early Anemia After HSCT

Efficacy and Safety of Olverembatinib Plus Inotuzumab Ozogamicin as First-Line Consolidation Therapy Followed by HSCT in Ph+ ALL

Neurocognitive Deficit After Paediatric Transplantation: Understanding the Role of Environment and Physical Function

Romiplostim N01 for Platelet Recovery After Haploidentical HSCT

Study of Treosulfan-Based Conditioning for HSCT in Nijmegen Breakage Syndrome

Zuberitamab for EBV Infection Post-Allo-HSCT

Modified Conditioning Regimen for CML-BP

Reduced Post-transplant Cyclophosphamide Dose in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation for Hematological Malignancies

Cardiovascular Complications in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.

Reduced-dose Conditioning Regimen Containing TBI in HSCT Treating Elderly Patients With Aplastic Anemia

Olverembatinib as Maintenance Therapy or Preemptive Therapy After Allo-HSCT in Ph+ALL

Comparison of Intralipid With SMOF Lipid Following HSCT

Patient Reported Outcomes and Patient Education in Cellular Therapy Patients

Efficacy and Safety of Azacitidine Combined With Interferon in the Treatment of Post-transplant Recurrence

Modification of the Human Colon and Oral Microbiome by Allogenic HSCT

Impact of the Lack of CMV-Specific CD8+ T Cell Response in CMV-Seropositive Donors in CMV Reactivation After Hematopoietic Stem Cells Transplant in CMV-Seropositive Recipients